Dual inhibition of ATR and PARP reverses acquired PARP inhibitor resistance in triple negative breast cancer

Abstract Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) have attracted significant attention in triple negative breast cancer (TNBC) treatment. However, the acquired or de novo PARP inhibitor resistance limits treatment success. Ataxia telangiectasia and Rad3-related (ATR) regulates genome in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Gamze Guney Eskiler, Ayten Haciefendi, Kayhan Ozdemir, Cemil Bilir
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer 2025-11-01
Col·lecció:	Discover Oncology
Matèries:	Triple negative breast cancer cells PARP inhibitors ATR inhibitors PARP inhibitor resistance
Accés en línia:	https://doi.org/10.1007/s12672-025-03844-x
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!